VYNE THERAPEUTICS INC. (VYNE) Operating income 2016–2025
VYNE THERAPEUTICS INC. (VYNE) annual operating income history from SEC filings — each fiscal year as reported.
-$29.7MFY2025 · since FY2016: -$14.3M → -$29.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.7M | +31.8% |
| FY2024 | -$43.6M | -49.1% |
| FY2023 | -$29.3M | +14.7% |
| FY2022 | -$34.3M | +11.9% |
| FY2021 | -$38.9M | +84.6% |
| FY2020 | -$252.5M | -163.4% |
| FY2019 | -$95.9M | -28.0% |
| FY2018 | -$74.9M | -153.1% |
| FY2017 | -$29.6M | -106.5% |
| FY2016 | -$14.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice